Yuki Ikeda

791 total citations
57 papers, 537 citations indexed

About

Yuki Ikeda is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yuki Ikeda has authored 57 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Yuki Ikeda's work include Cardiovascular Function and Risk Factors (13 papers), Heart Failure Treatment and Management (13 papers) and Cardiac pacing and defibrillation studies (11 papers). Yuki Ikeda is often cited by papers focused on Cardiovascular Function and Risk Factors (13 papers), Heart Failure Treatment and Management (13 papers) and Cardiac pacing and defibrillation studies (11 papers). Yuki Ikeda collaborates with scholars based in Japan, Netherlands and United Kingdom. Yuki Ikeda's co-authors include Junya Ako, Takayuki Inomata, Shunsuke Ishii, Takeru Nabeta, Toshimi Koitabashi, Yuichiro Iida, Teppei Fujita, Takashi Naruke, Ichiro Takeuchi and Emi Maekawa and has published in prestigious journals such as Circulation, Hypertension and European Heart Journal.

In The Last Decade

Yuki Ikeda

50 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Ikeda Japan 13 321 149 122 59 56 57 537
Filippo Scalise Italy 15 416 1.3× 137 0.9× 92 0.8× 70 1.2× 30 0.5× 44 608
Stamatios Lerakis United States 11 287 0.9× 91 0.6× 95 0.8× 62 1.1× 30 0.5× 29 515
Wen-Hsien Lee Taiwan 15 526 1.6× 168 1.1× 110 0.9× 136 2.3× 36 0.6× 79 722
Theodoros Zografos Greece 18 732 2.3× 228 1.5× 134 1.1× 80 1.4× 92 1.6× 67 1.2k
Sinan Arsan Türkiye 14 258 0.8× 231 1.6× 160 1.3× 24 0.4× 40 0.7× 71 666
Dimitrios Konstantinou Greece 12 562 1.8× 129 0.9× 118 1.0× 35 0.6× 80 1.4× 30 786
Suhas S. Lele India 14 373 1.2× 89 0.6× 94 0.8× 32 0.5× 44 0.8× 21 679
Iolanda Enea Italy 14 648 2.0× 83 0.6× 131 1.1× 33 0.6× 81 1.4× 33 867
Makoto Suzuki Japan 16 383 1.2× 144 1.0× 69 0.6× 97 1.6× 75 1.3× 62 702
Anilkumar Mehra United States 15 640 2.0× 220 1.5× 158 1.3× 107 1.8× 67 1.2× 40 814

Countries citing papers authored by Yuki Ikeda

Since Specialization
Citations

This map shows the geographic impact of Yuki Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Ikeda more than expected).

Fields of papers citing papers by Yuki Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Ikeda. The network helps show where Yuki Ikeda may publish in the future.

Co-authorship network of co-authors of Yuki Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Ikeda. A scholar is included among the top collaborators of Yuki Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Ikeda. Yuki Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanzaki, Shinya, et al.. (2024). Short Physical Performance Battery and Cardio-Ankle Vascular Index Association in Older Patients with Heart Failure. International Heart Journal. 65(5). 866–872. 2 indexed citations
2.
Nabeta, Takeru, Teppei Fujita, Yuichiro Iida, et al.. (2024). Non-Dilated Left Ventricular Cardiomyopathy vs. Dilated Cardiomyopathy: Clinical Background and Outcomes. ESC Heart Failure. 11(3). 1463–1471. 7 indexed citations
3.
Fukuda, Makoto, et al.. (2023). Pseudohypercreatininemia after surgery for aortic dissection: a case report. BMC Nephrology. 24(1). 220–220.
4.
Nakata, Jun, Takeshi Yamamoto, Keita Saku, et al.. (2023). Mechanical circulatory support in cardiogenic shock. Journal of Intensive Care. 11(1). 64–64. 21 indexed citations
6.
Nozaki, Kohei, Nobuaki Hamazaki, Yuki Ikeda, et al.. (2021). Hemodynamic Changes During Neuromuscular Electrical Stimulation and Mobility Therapy for an Advanced Heart Failure Patient with Impella 5.0 Device. International Heart Journal. 62(3). 695–699. 1 indexed citations
7.
Nabeta, Takeru, Shunsuke Ishii, Yuki Ikeda, et al.. (2020). Late Gadolinium Enhancement for Re-Worsening Left Ventricular Ejection Fraction in Patients with Dilated Cardiomyopathy. ESC Heart Failure. 8(1). 615–624. 7 indexed citations
8.
Nabeta, Takeru, Takayuki Inomata, Teppei Fujita, et al.. (2020). Clinical significance of left atrial geometry in dilated cardiomyopathy patients: A cardiovascular magnetic resonance study. Clinical Cardiology. 44(2). 222–229. 8 indexed citations
9.
Inomata, Takayuki, Yoshiyasu Minami, Teppei Fujita, et al.. (2018). Importance of Early Diagnosis of Cardiac Sarcoidosis in Patients with Complete Atrioventricular Block. International Heart Journal. 59(4). 772–778. 13 indexed citations
10.
Ikeda, Yuki, Takayuki Inomata, Keisuke Kida, et al.. (2018). Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR. Heart and Vessels. 34(3). 442–451. 7 indexed citations
11.
Nabeta, Takeru, Takayuki Inomata, Shunsuke Ishii, et al.. (2018). Dilated cardiomyopathy with re-worsening left ventricular ejection fraction. Heart and Vessels. 34(1). 95–103. 11 indexed citations
13.
Nabeta, Takeru, Takayuki Inomata, Yuichiro Iida, et al.. (2015). Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management. Heart and Vessels. 31(7). 1109–1116. 11 indexed citations
14.
Ikeda, Yuki, Takayuki Inomata, Yuichiro Iida, et al.. (2015). Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy. Heart and Vessels. 31(4). 545–554. 28 indexed citations
15.
Kitasato, Lisa, Takao Shimohama, Yuki Ikeda, et al.. (2015). Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES). Biomedicine & Pharmacotherapy. 72. 6–10. 6 indexed citations
16.
18.
Kishi, Takayuki, et al.. (2011). A case of endocapillary glomerulonephritis associated with peripheral blood natural killer cell proliferation. Clinical Kidney Journal. 4(5). 307–309. 2 indexed citations
19.
Obata, Fumiya, Kazunari Yoshida, M Ohkubo, et al.. (2004). Contribution of CD4+ and CD8+ T cells and interferon-gamma to the progress of chronic rejection of kidney allografts: the Th1 response mediates both acute and chronic rejection. Transplant Immunology. 14(1). 21–25. 37 indexed citations
20.
Ikeda, Yuki, et al.. (1994). Clinical Significance of Microalbuminuria in Elderly Diabetic Patients.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 31(8). 616–620. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026